Search results for:
Steriwave use expanded following successful pilot
Alberta Health Services has expanded its use of Steriwave nasal photodisinfection to reduce the incidence of surgical site infections (SSIs) in orthopedic surgery following a successful pilot at the Mazankowski Alberta Heart Institute Vancouver, British Columbia, Canada - October 31, 2023 SSIs, the most [...]
66.5% reduction in spine surgery infection rate
Pre-surgical Steriwave® nasal photodisinfection protocol contributed to 66.5% reduction in spine surgery infection rates and $2.5 million annual savings in Vancouver General Hospital Vancouver, British Columbia, Canada - October 23, 2023 Canadian life sciences company, Ondine Biomedical Inc. (OBI: LON), reports new independent research findings [...]
Steriwave shown to reduce resistant bacteria by >99.9%
Steriwave shown to reduce resistant bacteria by >99.9% Read article in The Microbiologist Vancouver, British Columbia, Canada - October 18, 2023 New research presented by Ondine shows that Steriwave photodisinfection reduces antibiotic-resistant bacteria by more than 99.9% without generating resistance. The research suggests [...]
Steriwave available coast-to-coast across Canada
Nova Scotia’s largest hospital is the latest to implement Steriwave nasal photodisinfection for use prior to orthopedic surgery Vancouver, British Columbia, Canada - October 13, 2023 Canadian life sciences company Ondine Biomedical’s (LON: OBI) Steriwave® nasal photodisinfection for the prevention of healthcare-associated infections (HAIs) is [...]
Montreal Heart Institute pilots Steriwave
Second Quebec-based hospital pilots nasal photodisinfection to reduce antibiotic resistance Vancouver, British Columbia, Canada - September 21, 2023 The world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era [...]
Steriwave proven highly effective against XDR bacteria
Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023, Geneva Vancouver, British Columbia, Canada - September 14, 2023 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention & [...]
Ondine receives funding for meat photodisinfection
Ondine Biomedical receives Agriculture and Agri-Food Canada (AAFC) funding to improve food security and increase shelf-life through photodisinfection Vancouver, British Columbia, Canada - December 5, 2022 Funding of up to $735,000 towards development of prototype of novel photodisinfection application for use in food production. Up [...]
Ondine reports full results from Phase 2 nasal photodisinfection trial
Ondine Biomedical reports the full results from Phase 2 nasal photodisinfection trial Vancouver, British Columbia, Canada - December 5, 2022 Full results confirm that a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients. [...]
Ondine cuts COVID-19 rate in food processing plant
Food processing plant sees huge reduction in employee COVID-19 rates after using nasal photodisinfection New research suggests that nasal photodisinfection could significantly reduce employee COVID-19 positive rates at food processing facilities Vancouver, British Columbia, Canada - November 7, 2022 Research presented last week at [...]
Ondine’s President and CTO receives IPA Lifetime Achievement Award
Ondine’s Dr. Nicolas Loebel receives IPA Lifetime Achievement Award for photodisinfection advancements Vancouver, British Columbia, Canada - October 31, 2022 Nicolas Loebel, Nicolas Loebel, President &Chief Technology Officer at Ondine Biomedical Inc. Dr. Nicolas Loebel, President and Chief Technology officer of Ondine Biomedical [...]
For Media Information
Simon Vane Percy
Amanda Bernard
